Alkermes plc (ALKS) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Alkermes Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.096 Greetings, and welcome to the Alkermes Second Quarter 2025 Financial Results Conference 00:00:04.096 -- 00:00:07.980 Call. My name is Rob, and I'll be your operator for today's call. 00:00:07.980 -- 00:00:11.584 All participant lines will be placed on mute to prevent background noise. 00:00:11.584 -- 00:00:15.228 If you should require operator assistance during the call, please press star zero from 00:00:15.228 -- 00:00:17.291 your telephone keypad. 00:00:17.291 -- 00:00:20.394 Please note that this conference is being recorded. 00:00:20.394 -- 00:00:24.499 I'll now turn the call over to Sandra Coombs, Senior Vice President of Investor Relations 00:00:24.499 -- 00:00:28.516 and Corporate Affairs. Sandy, you may now begin. 00:00:28.516 -- 00:00:32.883 Good morning. Welcome to the Alkermes PLC conference call to discuss our financial results 00:00:32.883 -- 00:00:36.750 and business update for the quarter-ended June 30th, 2025. 00:00:36.750 -- 00:00:41.938 With me today are Richard Pops, our CEO, Blair Jackson, our Chief Operating Officer, 00:00:41.938 -- 00:00:44.683 Todd Nichols, our Chief Commercial Officer, Dr. 00:00:44.683 -- 00:00:48.469 Craig Hopkinson, our Chief Medical Officer, and Dr. 00:00:48.469 -- 00:00:51.694 Marcus Yance, Vice President of Clinical Development. 00:00:51.694 -- 00:00:56.755 A slide presentation along with our press release, related financial tables, and reconciliations 00:00:56.755 -- 00:01:00.681 of the GAAP to non-GAAP financial measures that we'll discuss today are available on 00:01:00.681 -- 00:01:03.386 the investor section of Alkermes.com. 00:01:03.386 -- 00:01:07.172 We believe the non-GAAP financial results in conjunction with the GAAP results are useful 00:01:07.172 -- 00:01:10.658 in understa...